Uriblo 40 Number 140 (Paramesh Banerji Life Sciences LLC)


Welcome to the PulseAid listing for the Uriblo 40 Number 140 drug offered from Paramesh Banerji Life Sciences LLC. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: Paramesh Banerji Life Sciences LLC
NON-PROPRIETARY NAME: Arnica montana, Cantharis
SUBSTANCE NAME: ARNICA MONTANA; LYTTA VESICATORIA
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: PELLET
MARKETING CATEGORY NAME: UNAPPROVED HOMEOPATHIC
START MARKETING DATE: 2015-02-21
END MARKETING DATE: 0000-00-00


Uriblo 40 Number 140 HUMAN OTC DRUG Details:

Item DescriptionUriblo 40 Number 140 from Paramesh Banerji Life Sciences LLC
LABELER NAME: Paramesh Banerji Life Sciences LLC
DEA SCHEDULE:
ACTIVE STRENGTH: 200; 30([hp_C]/1; [hp_C]/1)
START MARKETING DATE: 2015-02-21
END MARKETING DATE: 0000-00-00
PRODUCT ID: 69152-0140_0f993d38-7b4a-143c-e054-00144ff8d46c
PRODUCT NDC: 69152-0140
APPLICATION NUMBER:

Other ARNICA MONTANA; LYTTA VESICATORIA Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Paramesh Banerji Life Sciences LLCUriblo 40 Number 140